A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

QR Code

A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

Context: Synthetic cannabinoids (SCs) such as “Spice”, “K2”, etc. are widely available via the internet despite increasing legal restrictions. Currently, the prevalence of use is typically low in the general community (<1%) although it is higher among students and some niche groups subject to dru...

Full description

Bibliographic Details
Main Authors:	Tait, Robert, Caldicott, D., Mountain, D., Hill, S., Lenton, Simon
Format:	Journal Article
Published:	2015
Online Access:	http://hdl.handle.net/20.500.11937/44051

Similar Items

Patterns of synthetic cannabinoid use in Australia
by: Barratt, Monica, et al.
Published: (2012)

The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products
by: Winstock, A., et al.
Published: (2013)

Synthetic cannabinoids: undesirable alternatives to natural marijuana
by: Palamar, J., et al.
Published: (2016)

Synthetic cannabinoid use among high school seniors
by: Palamar, J., et al.
Published: (2017)

Online alcohol interventions, sexual violence and intimate partner violence: A systematic review
by: Tait, Robert, et al.
Published: (2015)

Cannabinoids in experimental stroke: a systematic review and meta-analysis
by: England, Timothy J., et al.
Published: (2015)

The use of cannabinoids in colitis: a systematic review and meta-analysis
by: Couch, Daniel G., et al.
Published: (2018)

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.
by: Spry, N., et al.
Published: (2006)

Extracting adverse drug events from clinical notes: a systematic review of approaches used
by: Modi, Salisu, et al.
Published: (2024)

Characterization and analysis of neurologic adverse events associated with COVID-19 vaccination (S12.006)
by: Boruah, Abhilasha, et al.
Published: (2022)

Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis
by: Lamy, F., et al.
Published: (2017)

Association of ambulance response time and major adverse cardiac events in acute coronary syndrome
by: Shen, Jeremiah Ding Deck
Published: (2018)

Peri-operative adverse respiratory events in children
by: Von Ungern-Sternberg, B., et al.
Published: (2015)

The effects of cannabinoids on insulin secretion
by: Anderson, Richard L.
Published: (2011)

Commentary on Williams et al. (2014): Family matters—new resources for managing opioid overdose with take-home naloxone
by: Tait, Robert, et al.
Published: (2014)

Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids
by: Brook, E., et al.
Published: (2019)

Adverse events and tolerability of combined durvalumab and tremelimumab versus durvalumab alone in solid cancers: a systematic review and meta-analysis
by: Fahmy, Omar, et al.
Published: (2022)

Effects of intermittent preventive treatment with two doses of sulphadoxine-pyrimethamine in malaria infection and its associated adverse pregnancy outcomes: a systematic review
by: Balami, Ahmed Dahiru, et al.
Published: (2018)

Shifting paradigms and arising concerns in severe hemophilia A treatment
by: Chandran, Rubhan, et al.
Published: (2024)

Serious adverse event reporting in investigator-initiated clinical trials
by: Wallace, S., et al.
Published: (2016)

The association between ambient air pollution and selected adverse pregnancy outcomes in China: A systematic review
by: Jacobs, M., et al.
Published: (2017)

Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women
by: Regan, Annette, et al.
Published: (2014)

Acute Risk Change: An Innovative Measure of Operative Adverse Events and Perioperative Team Performance
by: Coulson, T., et al.
Published: (2018)

Novel fenofibrate derivatives as cannabinoid receptor ligands
by: Spencer, Sarah Jane
Published: (2011)

Cannabinoid-mediated short-term plasticity in hippocampus
by: Zachariou, Margarita, et al.
Published: (2014)

Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
by: Constantinescu, Cris S., et al.
Published: (2018)

Neurological events reported after COVID-19 vaccines: an analysis of vaccine adverse event reporting system
by: Frontera, Jennifer A., et al.
Published: (2022)

Adverse drug events in Malaysia: medication-related admissions and pharmacists' experiences
by: Karuppannan, Mahmathi
Published: (2012)

Sensory gating and its modulation by cannabinoids: electrophysiological, computational and mathematical analysis
by: Zachariou, Margarita, et al.
Published: (2008)

Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation
by: Regan, Annette, et al.
Published: (2015)

Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality
by: Necyk, C., et al.
Published: (2014)

A systematic review of the adverse effects of tacrolimus in organ transplant patients .
by: Teh, Lay Kek, et al.
Published: (2011)

Effect of cannabinoid receptor ligands on microglial cell functions
by: Hassan, Samia
Published: (2013)

Investigating ligand-directed signalling at the cannabinoid receptor 2
by: Hourani, Wafa
Published: (2019)

Investigating the molecular basis of biased signalling at cannabinoid receptors
by: Dennis, Morgan Jane
Published: (2023)

Assessment of GPR18 pairing with putative cannabinoid ligands
by: Abdulrazzaq, Ghayth
Published: (2018)

Structural exploration of cannabinoid receptors using computational methods
by: Murali, Lahari
Published: (2020)

Chromatographic Methods For The Detection Of The Principal Cannabinoid Metabolite In Urine.
by: Vijayan, S., et al.
Published: (1990)

Deliberate self-harm, substance use and negative affect in nonclinical samples: A systematic review
by: Moller, C., et al.
Published: (2013)

Efficacy and adverse effects of doxazosin in the treatment of hypertension
by: Sirisinghe, Roland G.
Published: (1999)